Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02248844

Enrollment

667

Registered

2014-09-25

Start date

2014-09-26

Completion date

2017-08-14

Last updated

2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crow's Feet Lines, Lateral Canthal Lines

Brief summary

This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.

Interventions

BIOLOGICALBotulinum Toxin Type A

Botulinum toxin Type A injected into crow's feet line areas per clinical practice.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Subject and Investigator decision to treat crow's feet lines with Botox®

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
Number of Participants with Adverse Events	Up to 3 months

Secondary

Measure	Time frame
Investigator's Assessment of Change in Appearance of Crow's Feet Lines on a 3-Point Scale	Baseline, Up to 3 months
Subject's Assessment of Change in Appearance of Crow's Feet Lines on a 7-Point Scale	Baseline, Up to 3 months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026